How to Predict Adverse Immune Reactions to Implantable Biomaterials?: Horizon 2020 PANBioRA project - Development of an integrated biomaterial risk assessment testing system
Eur J Immunol
.
2019 Apr;49(4):517-520.
doi: 10.1002/eji.201970045.
Authors
Melanie Ungemach
1
,
Timo Doll
1
,
Nihal Engin Vrana
2
3
Affiliations
1
Steinbeis 2i GmbH, Steinhaeuserstrasse 12, 76135, Karlsruhe, Germany.
2
Protip Medical, 8 Place de l'Hopital, Strasbourg, France.
3
INSERM UMR 1121 "Biomaterials and Bioengineering, 11 Rue Humann, 67085, Strasbourg, France.
PMID:
30942902
DOI:
10.1002/eji.201970045
No abstract available
Publication types
News
Research Support, Non-U.S. Gov't
MeSH terms
Biocompatible Materials / adverse effects*
Humans
Immunity*
Prognosis
Prostheses and Implants / adverse effects*
Risk Assessment* / methods
Substances
Biocompatible Materials
Grants and funding
760921/Horizon 2020/International